These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24604613)

  • 1. FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein.
    Ning Y; Luo C; Ren K; Quan M; Cao J
    Mol Med Rep; 2014 May; 9(5):1982-8. PubMed ID: 24604613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1.
    Ning YX; Li QX; Ren KQ; Quan MF; Cao JG
    Oncol Lett; 2014 Jul; 8(1):295-300. PubMed ID: 24959264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.
    Ning Y; Li Q; Xiang H; Liu F; Cao J
    Oncol Rep; 2012 Jun; 27(6):1857-64. PubMed ID: 22447287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4'-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity.
    Ning Y; Xu M; Cao X; Chen X; Luo X
    Oncol Rep; 2017 Aug; 38(2):949-958. PubMed ID: 28627607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
    Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H
    Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.
    Xiang HL; Liu F; Quan MF; Cao JG; Lv Y
    World J Gastroenterol; 2012 Sep; 18(33):4618-26. PubMed ID: 22969238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1.
    Chen A; Xu C; Luo Y; Liu L; Song K; Deng G; Yang M; Cao J; Yuan L; Li X
    Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1267-1275. PubMed ID: 31750892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
    Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3‑derived sphere-forming cells.
    Tang AQ; Cao XC; Tian L; He L; Liu F
    Mol Med Rep; 2015 Mar; 11(3):2221-6. PubMed ID: 25405327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
    Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
    Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrigendum] FOXO3a‑mediated suppression of the self‑renewal capacity of sphere‑forming cells derived from the ovarian cancer SKOV3 cell line by 7‑difluoromethoxyl‑5,4'‑di‑n‑octyl genistein.
    Ning Y; Luo C; Ren K; Quan M; Cao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34542163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α.
    Liu J; Cao XC; Xiao Q; Quan MF
    Mol Med Rep; 2015 Jan; 11(1):665-9. PubMed ID: 25334018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
    Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
    Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of chrysin on sphere formation and CK2α expression of ovarian cancer stem-like cells derived from SKOV3 cell line].
    Li HZ; Chen YH; Fang YL; Zhong LY; Yuan QQ; Xu XY; Cao JG
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2013-6. PubMed ID: 27470961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and significance of pThr32-FOXO3a in human ovarian cancer.
    Lu M; Xiang J; Xu F; Wang Y; Yin Y; Chen D
    Med Oncol; 2012 Jun; 29(2):1258-64. PubMed ID: 21452041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
    Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
    Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.